Shree Ganesh Biotech India Ratios

Shree Ganesh Biotech India Ltd Ratios

The Shree Ganesh Biotech India Ltd Ratios page provides a complete fundamental analysis of Shree Ganesh Biotech India Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Shree Ganesh Biotech India Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Shree Ganesh Biotech India Ltd (NSE: , BSE: 539470) is currently trading at ₹0.59, with a market capitalization of ₹215.26M. As a major player in the Process industries sector and Agricultural commodities/Milling industry, Shree Ganesh Biotech India Ltd remains a key stock for fundamental analysis using Shree Ganesh Biotech India Ltd Ratios.

Shree Ganesh Biotech India Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Shree Ganesh Biotech India Ltd P/E ratio currently stands at 128.57, making it one of the most tracked metrics in Shree Ganesh Biotech India Ltd Ratios.

Historically, the Shree Ganesh Biotech India Ltd P/E ratio has shown strong fluctuations:

• 2024: 128.57
• 2023: 67.31
• 2022: 19.96
• 2021: 73.34
• 2020: 750

The rising Shree Ganesh Biotech India Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Shree Ganesh Biotech India Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.57.

Historical P/B trend:

• 2024: 0.57
• 2023: 0.66
• 2022: 0.65
• 2021: 3.07

Shree Ganesh Biotech India Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Shree Ganesh Biotech India Ltd P/S ratio currently stands at 1.56, an important part of Shree Ganesh Biotech India Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.56
• 2023: 2.06
• 2022: 0.65
• 2021: 2.55

A stable or declining Shree Ganesh Biotech India Ltd P/S ratio indicates cautious market sentiment.

Shree Ganesh Biotech India Ltd Price to Cash Flow Ratio (P/CF)

The Shree Ganesh Biotech India Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Shree Ganesh Biotech India Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 4.12
• 2022: 3.86
• 2021: 51.97
• 2020: 99.89

The declining Shree Ganesh Biotech India Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Shree Ganesh Biotech India Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Shree Ganesh Biotech India Ltd EV currently stands at ₹358.63M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 358.63M
• 2023: 414.28M
• 2022: 401.8M
• 2021: 1.85B

Shree Ganesh Biotech India Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Shree Ganesh Biotech India Ltd EV/EBITDA ratio is currently 0, a key metric in Shree Ganesh Biotech India Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 18.69
• 2021: 53.73

Stable Shree Ganesh Biotech India Ltd EV/EBITDA indicates balanced valuation.

Shree Ganesh Biotech India Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Shree Ganesh Biotech India Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Shree Ganesh Biotech India Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Shree Ganesh Biotech India Ltd ROE currently stands at 0.44%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.44
• 2023: 0.99
• 2022: 3.32
• 2021: 4.28

Declining ROE indicates pressure on profitability.

Shree Ganesh Biotech India Ltd Ratios Analysis Summary

The Shree Ganesh Biotech India Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Shree Ganesh Biotech India Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Shree Ganesh Biotech India Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.